Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to novel therapies. In this overview, PharmTech takes a look back at significant ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.